Rasa Kizlaitienė

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

Ludwig Kappos, Amit Bar‐Or, Bruce Cree et al. · The Lancet · 2018 · 925 citations

Medicine, Neurology, Pharmacology +9

The BICAMS Battery for Assessment of Lithuanian-Speaking Multiple Sclerosis Patients: Relationship with Age, Education, Disease Disability, and Duration

Nataša Giedraitienė, Rasa Kizlaitienė, Gintaras Kaubrys · Medical Science Monitor · 2015 · 51 citations · Full text

Medicine, Neurology, Psychology +17

Cognition During and After Multiple Sclerosis Relapse as Assessed With the Brief International Cognitive Assessment for Multiple Sclerosis

Nataša Giedraitienė, Gintaras Kaubrys, Rasa Kizlaitienė · Scientific Reports · 2018 · 37 citations · Full text

Medicine, Neurology, Neuroscience +17

Cognitive Decline in Multiple Sclerosis Is Related to the Progression of Retinal Atrophy and Presence of Oligoclonal Bands: A 5-Year Follow-Up Study

Nataša Giedraitienė, Eglė Drukteinienė, Rasa Kizlaitienė et al. · Frontiers in Neurology · 2021 · 23 citations · Full text

Life Sciences, Neurology, Neuroscience +15

Incidence rate and sex ratio in multiple sclerosis in Lithuania

Daiva Valadkevičienė, Andrius Kavaliūnas, Rasa Kizlaitienė et al. · Brain and Behavior · 2018 · 22 citations · Full text

Veterinary Medicine, Health Sciences, Neurology +14